Viscosupplementation products and stem cell-based biologics dominate the product mix, particularly in osteoarthritis and joint regeneration applications. https://www.einpresswire.com/article/835005545/orthobiologics-market-to-hit-7-85b-by-2032-driven-by-aging-population-and-regenerative-medicine-advances